The vegetative and minimally conscious states in children: Spasticity, muscle contracture and issues for physiotherapy treatment

Brain Injury

Volumn 16, Issue 3, 2002, Pages 217-230

  Leong, Bentley ^a  

^a BC CHILDREN S HOSPITAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

BACLOFEN; BENZODIAZEPINE; BOTULINUM TOXIN; DANTROLENE; DIAZEPAM; PHENOL;

CONNECTIVE TISSUE; CONSCIOUSNESS; CONVALESCENCE; DRUG CEREBROSPINAL FLUID LEVEL; DRUG EFFICACY; FAMILY; HEALTH CARE COST; HUMAN; MANIPULATIVE MEDICINE; MEDICAL ETHICS; MUSCLE CONTRACTURE; MUSCLE FIBER CONTRACTION; MUSCLE TONE; NEUROPATHOLOGY; PATHOPHYSIOLOGY; PERSISTENT VEGETATIVE STATE; PHYSIOTHERAPY; REHABILITATION MEDICINE; REVIEW; RHIZOTOMY; SIDE EFFECT; SPASTICITY; TEAMWORK; UNCONSCIOUSNESS;

EID: 0036124947     PISSN: 02699052     EISSN: None     Source Type: Journal    
DOI: 10.1080/02699050110103283     Document Type: Review

References (100)

1. Special article: Medical aspects of the persistent vegetative state: Part 1
2. Life expectancy of children in vegetative and minimally conscious states
3. Outcome of children with prolonged unconsciousness and vegetative states
4. Life expectancy of children in a persistent vegetative state
5. The persistent vegetative state in children: Report of the child neurology society ethics committee
6. Traumatic brain injury outcome: Concepts for emergency care
7. Head injury: Recent past, present, and future
8. Contractures: A major complication of craniocerebral trauma
9. Neuropathology of the persistent vegetative state: A review
10. Some neurophysiologic aspects of consciousness
11. The neuropathology of the vegetative state after head injury
12. The neuropathology of the vegetative state after an acute brain insult
13. Neuropathology in vegetative and severely disabled patients after head injury
14. Symposium synopsis
15. Stretch reflex dynamics in spastic elbow flexor muscles
16. Trends in the pathophysiology and pharmacotherapy of spasticity
17. Spasticity: A review
18. Spastic hypertonia: Mechanisms and measurement
19. Quantitative relations between hypertonia and stretch reflex threshold in spastic hemiparesis
20. The spastic mouse and the search for an animal model of spasticity in human beings
21. Pathophysiology of spasticity
22. The physiological and anatomical basis of spasticity: A review
23. Is there an animal model of spasticity
24. Spinal mechanisms underlying spasticity
25. Tizanidine and electrophysiologic analysis of spinal control mechanisms in humans with spasticity
26. Human monosynaptic reflexes and presynaptic inhibition
27. A reflex technique to measure presynaptic inhibition in cerebral stroke
28. Reciprocal inhibition between forearm muscles in spastic hemiplegia
29. Deficits in reciprocal inhibition of children with cerebral palsy as revealed by H reflex testing
30. Reciprocal inhibition in hemiplegia: Correlation with clinical features and recovery
31. H-reflex recovery curve and reciprocal inhibition of H-reflex of the upper limbs in patients with spasticity secondary to stroke
32. Short-latency autogenic inhibition (IB inhibition) in human spasticity
33. Presynaptic inhibition and homosynaptic depression: A comparison between lower and upper limbs in normal human subjects and patients with hemiplegia
34. A qualitative assessment of presynaptic inhibition of Ia afferents in spastics: Differences in hemiplegics and paraplegics
35. Presynaptic inhibition in humans: A comparison between normal and spastic patients
36. Recurrent inhibition of alpha-motoneurons in patients with upper motor neuron lesions
37. Electrophysiological studies of gait in spasticity and rigidity: Evidence that altered mechanical properties of muscle contribute to hypertonia
38. Joint dependent passive stiffness in paretic and contralateral limbs of spastic patients with hemiparetic stroke
39. Chronic transformation of muscle in spasticity: A peripheral contribution to increased tone
40. Passive, intrinsic and reflex-mediated stiffness in the ankle extensors of hemiparetic patients
41. Biomechanical changes at the ankle joint after stroke
42. Pathology of spastic muscle in cerebral palsy
43. Muscle pathology and clinical measures of disability in children with cerebral palsy
44. Muscle histopathology in spastic cerebral palsy
45. Motor unit involvement in spastic paresis: Relationship between leg muscle activation and histochemistry
46. Histology and intramuscular pressure in spastic muscle
47. Spasticity and contracture: Physiologic aspects of formation
48. The effect of immobilization on the longitudinal growth of striated muscle fibres
49. Effects of immobilization on the extensibility of periarticular connective tissue
50. Effects of immobilization on joints
51. The intra-articular effects of immobilization on the human knee
52. Experimental rapid sarcomere loss with concomitant hypoextensibility
53. Spasticity and muscle contracture following stroke
54. Motor profile of patients in minimally responsive and persistent vegetative states
55. Management of a patient diagnosed as PVS
56. Spasticity as an adaptation to pyramidal tract injury
57. Traditional pharmacological treatments for spasticity part I: Local treatments
58. Comparison of phenol block and botulinum toxin type A in the treatment of spastic foot after stroke: A randomized, double-blind trial
59. Mechanisms of action of phenol block and botulinum toxin type A in relieving spasticity: Electrophysiologic investigation and follow-up
60. Percutaneous phenol blocks to motor points of spastic forearm muscles in head-injured adults
61. Percutaneous phenol block of the musculocutaneous nerve to control elbow flexor spasticity
62. Botulinum toxin A compared with stretching casts in the treatment of spastic equinus: A randomised prospective trial
63. Botulinum toxin A versus fixed cast stretching for dynamic calf tightness in cerebral palsy
64. Botulinum toxin A in the treatment of spasticity: Functional implications and patient selection
65. Botulinum toxin type A in the treatment of upper extremity spasticity: A randomized, double-blind, placebo-controlled trial
66. Botulinum toxin in severe upper extremity spasticity among patients with traumatic brain injury: An open-labeled trial
67. Traditional pharmacological treatments for spasticity part II: General and regional treatments
68. Continuous intrathecal baclofen infusion for spasticity of cerebral origin
69. Spasticity
70. The surgical treatment of spasticity
71. Effects of continuous intrathecal baclofen infusion and selective posterior rhizotomy on upper extremity spasticity
72. Intrathecally administered baclofen for treatment of children with spasticity of cerebral origin
73. Continuous intrathecal baclofen infusion in severe spasticity after traumatic or hypoxic brain injury
74. Long-term continuously infused intrathecal baclofen for spastic-dystonic hypertonia in traumatic brain injury: 1-year experience
75. Continuously infused intrathecal baclofen over 12 months for spastic hypertonia in adolescents and adults with cerebral palsy
76. Prospective assessment of continuous intrathecal infusion of baclofen for spasticity caused by acquired brain injury: A preliminary report
77. Intrathecal baclofen for intractable cerebral spasticity: A prospective placebo-controlled, double-blind study
78. Intrathecal baclofen infusion and subsequent orthopedic surgery in patients with spastic cerebral palsy
79. Functional outcomes following selective posterior rhizotomy in children with cerebral palsy
80. A randomized clinical trial to compare selective posterior rhizotomy plus physiotherapy with physiotherapy alone in children with spastic diplegic cerebral palsy
81. Evaluation of selective dorsal rhizotomy for the reduction of spasticity in cerebral palsy: A randomized controlled trial
82. Continuum of reflex excitability in hemiplegia: Influence of muscle length and muscular transformation after heel-cord lengthening and immobilization on the pathophysiology of spasticity and clonus
83. Stretch reflex adaptation in elbow flexors during repeated passive movements in unilateral brain-injured patients
84. Effects of prolonged muscle stretch on reflex and voluntary muscle activations in children with spastic cerebral palsy
85. Effect of serial casting for the prevention of equinus in patients with acute head injury
86. The effects of casting on upper extremity motor disorders after brain injury
87. The effect of casting combined with stretching on passive ankle dorsiflexion in adults with traumatic head injuries
88. Multimodality treatment of joint contractures in patients with severe brain injury: Cost, effectiveness, and integration of therapies in the application of serial/inhibitive casts
89. The surgical treatment of spasticity
90. Special article: Medical aspects of the persistent vegetative state: Part 2
91. Reflex hyperexcitability and muscle contracture in relation to spastic hypertonia
92. Family reactions to persistent vegetative state
93. Functional status and therapeutic intensity during inpatient rehabilitation
94. Summary report: Evidence for the effectiveness of rehabilitation for persons with traumatic brain injury
95. Vegetative state after closed-head injury: A traumatic coma data bank report
96. Outcome after severe traumatic brain injury: Coma, the vegetative state and the minimally conscious state
97. Recovery of patients after four months or more in the persistent vegetative state
98. Ethical issues in the management of persistent vegetative state
99. Treating the patient to benefit others
100. The persistent vegetative state and anencephaly: Problematic paradigms for discussing futility and rationing